...F, Pires C, Bassani-Sternberg M, Svane I, Pereira CF. Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming. Science Immunology 8, eadd4817 (2023).
Rosa FF, Pires CF, Kurochkin I, Halitzki E, Zahan T, Arh N, Zimmermannová O, Ferreira AG, Li H, Karlsson S...
...Reprogramming in Hematopoiesis and Immunity Lab at Lund University (
Profile
Scientist/Senior Scientist with background in tumor immunology to work in the experimental validation of AT-108. The candidate will focus on both efficacy and safety studies in multiple...
...pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions.
Our broad therapeutic pipeline based on the company’s proprietary IgG-cleaving enzyme technology platform has potential...
...Reprogramming in Hematopoiesis and Immunity Lab at Lund University (
Profile
Scientist/Senior Scientist with background in tumor immunology to work in the experimental validation of AT-108. The candidate will be responsible for establishing patient-derived monolayer...